Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025978031> ?p ?o ?g. }
- W2025978031 abstract "Acquisition of mesenchymal characteristics confers to breast cancer (BC) cells the capability of invading tissues different from primary tumor site, allowing cell migration and metastasis. Regulators of the mesenchymal-epithelial transition (MET) may represent targets for anticancer agents. Accruing evidence supports functional implications of choline phospholipid metabolism in oncogene-activated cell signaling and differentiation. We investigated the effects of D609, a xanthate inhibiting phosphatidylcholine-specific phospholipase C (PC-PLC) and sphingomyelin synthase (SMS), as a candidate regulator of cell differentiation and MET in the highly metastatic BC cell line MDA-MB-231. PC-PLC expression and activity were investigated using confocal laser scanning microscopy (CLSM), immunoblotting and enzymatic assay on human MDA-MB-231 compared with MCF-7 and SKBr3 BC cells and a nontumoral immortalized counterpart (MCF-10A). The effects of D609 on PC-PLC and SMS activity, loss of mesenchymal markers and changes in migration and invasion potential were monitored in MDA-MB-231 cells by enzymatic assays, CLSM, immunoblotting and transwell chamber invasion combined with scanning electron microscopy examinations. Cell proliferation, formation and composition of lipid bodies and cell morphology were investigated in D609-treated BC cells by cell count, CLSM, flow-cytometry of BODIPY-stained cells, nuclear magnetic resonance and thin-layer chromatography. PC-PLC (but not phospholipase D) showed 2- to 6-fold activation in BC compared with nontumoral cells, the highest activity (up to 0.4 pmol/μg protein/min) being detected in the poorly-differentiated MDA-MB-231 cells. Exposure of the latter cells to D609 (50 μg/mL, 24-72 h) resulted into 60-80% PC-PLC inhibition, while SMS was transiently inhibited by a maximum of 21%. These features were associated with progressive decreases of mesenchymal traits such as vimentin and N-cadherin expression, reduced galectin-3 and milk fat globule EGF-factor 8 levels, β-casein formation and decreased in vitro cell migration and invasion. Moreover, proliferation arrest, changes in cell morphology and formation of cytosolic lipid bodies typical of cell differentiation were induced by D609 in all investigated BC cells. These results support a critical involvement of PC-PLC in controlling molecular pathways responsible for maintaining a mesenchymal-like phenotype in metastatic BC cells and suggests PC-PLC deactivation as a means to promote BC cell differentiation and possibly enhance the effectiveness of antitumor treatments." @default.
- W2025978031 created "2016-06-24" @default.
- W2025978031 creator A5013878821 @default.
- W2025978031 creator A5015047690 @default.
- W2025978031 creator A5028609419 @default.
- W2025978031 creator A5029001269 @default.
- W2025978031 creator A5030891576 @default.
- W2025978031 creator A5040236379 @default.
- W2025978031 creator A5054158026 @default.
- W2025978031 creator A5074354918 @default.
- W2025978031 creator A5078833835 @default.
- W2025978031 date "2012-03-19" @default.
- W2025978031 modified "2023-10-09" @default.
- W2025978031 title "Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells" @default.
- W2025978031 cites W1276003021 @default.
- W2025978031 cites W1567527369 @default.
- W2025978031 cites W1969788761 @default.
- W2025978031 cites W1973863600 @default.
- W2025978031 cites W1973890143 @default.
- W2025978031 cites W1976062171 @default.
- W2025978031 cites W1984906223 @default.
- W2025978031 cites W1991328178 @default.
- W2025978031 cites W1999800890 @default.
- W2025978031 cites W2000463265 @default.
- W2025978031 cites W2001981455 @default.
- W2025978031 cites W2007095168 @default.
- W2025978031 cites W2007956014 @default.
- W2025978031 cites W2009471786 @default.
- W2025978031 cites W2014691022 @default.
- W2025978031 cites W2015254024 @default.
- W2025978031 cites W2019257805 @default.
- W2025978031 cites W2020058751 @default.
- W2025978031 cites W2023339355 @default.
- W2025978031 cites W2027325804 @default.
- W2025978031 cites W2037680351 @default.
- W2025978031 cites W2046639538 @default.
- W2025978031 cites W2048671328 @default.
- W2025978031 cites W2050417061 @default.
- W2025978031 cites W2055505762 @default.
- W2025978031 cites W2063785611 @default.
- W2025978031 cites W2064438589 @default.
- W2025978031 cites W2064961943 @default.
- W2025978031 cites W2065877465 @default.
- W2025978031 cites W2069312908 @default.
- W2025978031 cites W2070058781 @default.
- W2025978031 cites W2072115509 @default.
- W2025978031 cites W2073067208 @default.
- W2025978031 cites W2075601790 @default.
- W2025978031 cites W2083166156 @default.
- W2025978031 cites W2086194783 @default.
- W2025978031 cites W2105772211 @default.
- W2025978031 cites W2109287818 @default.
- W2025978031 cites W2131837964 @default.
- W2025978031 cites W2136949790 @default.
- W2025978031 cites W2149504763 @default.
- W2025978031 cites W2150685056 @default.
- W2025978031 cites W2154129829 @default.
- W2025978031 cites W2159166873 @default.
- W2025978031 cites W2159330934 @default.
- W2025978031 cites W2162987503 @default.
- W2025978031 cites W2168526937 @default.
- W2025978031 doi "https://doi.org/10.1186/bcr3151" @default.
- W2025978031 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3446384" @default.
- W2025978031 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22429397" @default.
- W2025978031 hasPublicationYear "2012" @default.
- W2025978031 type Work @default.
- W2025978031 sameAs 2025978031 @default.
- W2025978031 citedByCount "57" @default.
- W2025978031 countsByYear W20259780312012 @default.
- W2025978031 countsByYear W20259780312013 @default.
- W2025978031 countsByYear W20259780312014 @default.
- W2025978031 countsByYear W20259780312015 @default.
- W2025978031 countsByYear W20259780312016 @default.
- W2025978031 countsByYear W20259780312017 @default.
- W2025978031 countsByYear W20259780312018 @default.
- W2025978031 countsByYear W20259780312019 @default.
- W2025978031 countsByYear W20259780312020 @default.
- W2025978031 countsByYear W20259780312021 @default.
- W2025978031 countsByYear W20259780312022 @default.
- W2025978031 countsByYear W20259780312023 @default.
- W2025978031 crossrefType "journal-article" @default.
- W2025978031 hasAuthorship W2025978031A5013878821 @default.
- W2025978031 hasAuthorship W2025978031A5015047690 @default.
- W2025978031 hasAuthorship W2025978031A5028609419 @default.
- W2025978031 hasAuthorship W2025978031A5029001269 @default.
- W2025978031 hasAuthorship W2025978031A5030891576 @default.
- W2025978031 hasAuthorship W2025978031A5040236379 @default.
- W2025978031 hasAuthorship W2025978031A5054158026 @default.
- W2025978031 hasAuthorship W2025978031A5074354918 @default.
- W2025978031 hasAuthorship W2025978031A5078833835 @default.
- W2025978031 hasBestOaLocation W20259780311 @default.
- W2025978031 hasConcept C121608353 @default.
- W2025978031 hasConcept C1491633281 @default.
- W2025978031 hasConcept C153911025 @default.
- W2025978031 hasConcept C185592680 @default.
- W2025978031 hasConcept C191560914 @default.
- W2025978031 hasConcept C198826908 @default.
- W2025978031 hasConcept C2779013556 @default.
- W2025978031 hasConcept C2994423619 @default.
- W2025978031 hasConcept C502942594 @default.